|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00950 LEE'S PHARM
Nominal 
1.250 +0.050 (+4.167%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Turnover | 658,345 | 28.506% | 512,308 | 649,166 | 584,052 | 556,716 |
| Cost of Sales | (307,750) | 35.070% | (227,845) | (229,688) | (197,506) | (191,097) |
| Gross Profit | 350,595 | 23.248% | 284,463 | 419,478 | 386,546 | 365,619 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (253) | (419) | (587) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (239) | -45.682% | (440) | (526) | (3,311) | (6,039) | |
| Profit / (Loss) before Taxation | 61,108 | 124.761% | 27,188 | 51,795 | 2,137,279 | 105,258 | |
| Taxation | (6,239) | -0.637% | (6,279) | (24,713) | (3,377) | (29,317) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 7,609 | -- | (4,792) | 1,378 | 21,298 | 21,041 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 62,478 | 287.653% | 16,117 | 28,460 | 2,155,200 | 96,982 | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Net Finance Costs / (Income) | 5,705 | 19.426% | 4,777 | 2,316 | (531) | (2,137) |
| Depreciation & Amortisation | 70,452 | -9.383% | 77,747 | 78,536 | 70,762 | 55,125 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 10.610 | 287.226% | 2.740 | 4.830 | 366.240 | 16.490 |
| DPS (cts) | 2.000 | -- | 0.800 | 1.000 | 3.000 | 2.700 |
| Dividend Payout Ratio (%) | 18.850% | -- | 29.197% | 20.704% | 0.819% | 16.374% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.910 | -- | 3.352 | 3.637 | 6.001 | 3.652 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 62,478,000 |
| %Change | 287.653% |
| EPS / (LPS) | HKD 0.106 |
| NBV Per Share ($) | HKD 2.910 |